Strides Pharma Science Ltd

NSE: STAR · BSE: 532531 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,100.60
Market cap: ₹10,145 Cr
Revenue (annual): ₹4,859 Cr
Net profit (annual): ₹556.2 Cr
P/E (TTM): 16.5×Sector 47.3×
Promoter holding: 27.91%+0.00% QoQ
FII holding: 28.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Financial Results 4 Earnings Call 4 Business Update 4 Results Update 2 Other Announcement 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 May 2026 18:09 IST NSE

Board Meeting Outcome

Strides Pharma Science Board Meeting Outcome

Strides Pharma announced leadership elevations, senior management appointments, and recommended Deloitte as statutory auditors. These strategic changes aim to professionalize management and strengthen global operations.

Read the filing ↗